✦ LIBER ✦

Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: Results from the REPLACE-2 trial

✍ Scribed by David J. Cohen; A. Michael Lincoff; Tara A. Lavelle; Huei-Ling Chen; Ameet Bakhai; Ronna H. Berezin; Daniel Jackman; Ian J. Sarembock; Eric J. Topol

Book ID: 119264344
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 130 KB
Volume: 44
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2004.05.085

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bivalirudin versus heparin and glycoprot

Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial)

✍ Derek P. Chew; A. Michael Lincoff; Hitinder Gurm; Katherine Wolski; David J. Coh 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Provisional glycoprotein IIb/IIIa blocka

Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)–2 trial

✍ J. Emilio Exaire; Samuel M. Butman; Ramin Ebrahimi; Neal S. Kleiman; Robert A. H 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Lack of clopidogrel pretreatment effect

Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: A REPLACE-2 substudy

✍ J. Saw; A.M. Lincoff; W. DeSmet 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Lack of clopidogrel pretreatment effect

✍ Jacqueline Saw; A.Michael Lincoff; Walter DeSmet; Amadeo Betriu; Wolfgang Rutsch 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Safe and efficacious use of bivalirudin

Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition

✍ Leslie Cho; Derek P. Chew; David J. Moliterno; Marco Roffi; Stephen G. Ellis; Ir 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Comparison of Bivalirudin Versus Bivalir

Comparison of Bivalirudin Versus Bivalirudin Plus Glycoprotein IIb/IIIa Inhibitor Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Having Percutaneous Intervention for Narrowed Saphenous Vein Aorto-Coronary Grafts (the ACUITY Trial Investigators)

✍ Dinesh Kumar; George Dangas; Roxana Mehran; Ajay Kirtane; Michel Bertrand; Ramin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 152 KB